Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoliu Liang

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Cellular Biochemistry|February 19, 2019
Adverse impact of carbon tetrachloride on metabolic function in miceXiaoliu Liang, Ka Wu, Meizhen Liu, et al.
Biofactors (Oxford, England)|May 24, 2019
Potential biomarker of fibroblast growth factor 21 in valproic acid-treated liversXiaoxiao Xu, Chao Guo, Xiaoliu Liang, et al.
Pharmacological Research|September 29, 2019
Infliximab clinically treating ulcerative colitis: A systematic review and meta-analysisChao Guo, Ka Wu, Xiaoliu Liang, et al.
Environmental Toxicology and Pharmacology|August 4, 2019
Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cellsRui Zhou, Meizhen Liu, Xiaoliu Liang, et al.
Journal of Advanced Research|June 14, 2019
To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitisKa Wu, Pingyuan Wei, Meizhen Liu, et al.
International Immunopharmacology|December 12, 2018
Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: A study of network pharmacologyMin Su, Chao Guo, Meizhen Liu, et al.
Journal of Cellular and Molecular Medicine|June 5, 2019
Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acidRong Li, Xingyue Qin, Xiaoliu Liang, et al.
Environmental Toxicology and Pharmacology|December 15, 2018
Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stressMin Su, Xiaoliu Liang, Xiaoxiao Xu, et al.
European Journal of Pharmacology|June 8, 2020
Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology studyYujia Liang, Rui Zhou, Xiaoliu Liang, et al.
Environmental Science and Pollution Research International|May 2, 2019
Effect of prenatal PFOS exposure on liver cell function in neonatal miceXiaoliu Liang, Guojie Xie, Xinmou Wu, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|February 19, 2019
Adverse impact of carbon tetrachloride on metabolic function in miceXiaoliu Liang, Ka Wu, Meizhen Liu, et al.
Biofactors (Oxford, England)|May 24, 2019
Potential biomarker of fibroblast growth factor 21 in valproic acid-treated liversXiaoxiao Xu, Chao Guo, Xiaoliu Liang, et al.
Pharmacological Research|September 29, 2019
Infliximab clinically treating ulcerative colitis: A systematic review and meta-analysisChao Guo, Ka Wu, Xiaoliu Liang, et al.
Environmental Toxicology and Pharmacology|August 4, 2019
Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cellsRui Zhou, Meizhen Liu, Xiaoliu Liang, et al.
Journal of Advanced Research|June 14, 2019
To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitisKa Wu, Pingyuan Wei, Meizhen Liu, et al.
International Immunopharmacology|December 12, 2018
Therapeutic targets of vitamin C on liver injury and associated biological mechanisms: A study of network pharmacologyMin Su, Chao Guo, Meizhen Liu, et al.
Journal of Cellular and Molecular Medicine|June 5, 2019
Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acidRong Li, Xingyue Qin, Xiaoliu Liang, et al.
Environmental Toxicology and Pharmacology|December 15, 2018
Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stressMin Su, Xiaoliu Liang, Xiaoxiao Xu, et al.
European Journal of Pharmacology|June 8, 2020
Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology studyYujia Liang, Rui Zhou, Xiaoliu Liang, et al.
Environmental Science and Pollution Research International|May 2, 2019
Effect of prenatal PFOS exposure on liver cell function in neonatal miceXiaoliu Liang, Guojie Xie, Xinmou Wu, et al.
Pageof 2